ALS 886
Alternative Names: ALS-886Latest Information Update: 06 May 2011
At a glance
- Originator Baxter International
- Developer Advanced Life Sciences
- Class Anti-inflammatories; Benzoic acids; Small molecules
- Mechanism of Action Chelating agents; Free radical scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- Suspended Adult respiratory distress syndrome; Lung disorders
- No development reported Brain oedema
Most Recent Events
- 06 May 2011 Suspended - Preclinical for Adult respiratory distress syndrome in USA (unspecified route)
- 06 May 2011 Suspended - Preclinical for Lung disorders in United Kingdom (unspecified route)
- 17 Jul 2008 Preclinical trials in Lung disorders in United Kingdom (unspecified route)